JERUSALEM--(BUSINESS WIRE)--April 28, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA - News) announced today that it has been notified of an unsolicited so-called “mini-tender” offer by TRC Capital Corporation to purchase up to 2.5 million Teva ordinary shares in the form of American Depositary Shares (“ADSs”), representing less than 0.4% of Teva’s outstanding shares. TRC Capital’s offer price of $37.80 per share represents a 3.8% discount to the $39.31 per share closing price on Nasdaq of the ADSs on April 19, 2006, the day prior to the date of the offer, and is more than 7.6% below yesterday’s $40.92 per share Nasdaq closing price.
